These d exercice d angelique NALLET a Université de Bordeaux DES MI2C CEMI . SARS-CoV-2 et Evusheld chez les patients immuno-déprimés. Charles.Cazanave president de jury avec Noémie Gensous Nahéma. Fier de tous! Bravo! Future doc junior
YES!! Covid Solidarity Jess
Laura Miers
New Monoclonal Authorized to Prevent COVID in Immunocompromised People
— No such option has been available since FDA revoked the authorization of Evusheld last year medpagetoday.com/infectiousdise…
Liebe Swissmedic , wäre es möglich diesmal die Zulassung zu erteilen bevor das Medikament wegen Viraler Evolution schon Obsolet wird (wie im Fall von Evusheld)?
We have submitted our statement/evidence for Mod 4 of the UK Covid-19 Inquiry at the request of Baroness Hallett. This module covers vaccines and therapeutics, so it is a chance to tell the story relating to Evusheld and all the issues we have endured regarding vaccines.
Department of Health and Social Care
Taking notes for #longcovid :
Suboptimal response to combined Remdesivir + Evusheld treatment in immunocompromised patients with persistent Sars2 infection
We will likely need combination treatments but this is prob not the one
academic.oup.com/jac/advance-ar…
‼️⚠️ #IDTwitter , the upcoming “ #Evusheld 2.0” ( #AZD3152 ) by AstraZeneca does not work against the >60% of currently circulating S:F456L SARS-CoV-2.
congresspublication.com/media/cchh4bkc…
cov-spectrum.org/explore/World/…
@who,FDA EU Medicines Agency Janet Handal Bart Rijnders Arturo Casadevall emanuele nicastri